Alternatives to Precision BioSciences
Precision BioSciences is a Biotechnology tool: A clinical-stage biotechnology company developing in vivo gene editing therapies. Here are the 55 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Precision BioSciences
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
DiaMedica TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases.
CryoPortNot ratedGlobal provider of integrated temperature-controlled supply chain solutions for the life sciences industry.
Editas MedicineNot ratedA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Immitra BioNot ratedScalable, one-time curative in-vivo gene editing therapies.
SOLVE FSHDNot ratedVenture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Showing the next 20 closest matches. See the rest on the Precision BioSciences profile.
Sponsored rows are paid and labelled. Advertise on this page
